CXCL8 and metabolic syndrome: Interestingly, IL-8 has been shown to be an intermediate factor in AGE-mediated cell signaling [46], suggesting a role for IL-8 in the process linking radio- and chemotherapy treatment in young patients to low-grade inflammation and risk of metabolic syndrome.